Scroll To Top
Search by Speciality

Update in Rheumatology 2014: Highlights from the ACR and EULAR Meetings

University of California San Diego School of Medicine * | California, USA
From 15 to 25 USD
Event Preview
This event
is Finished
Title: Update in Rheumatology 2014: Highlights from the ACR and EULAR Meetings
Specialty: Rheumatology
Dates: From Dec, 13, 2014 to Dec, 13, 2014
Location: California, USA
Type: Meeting
Registration Cost: From 15 to 25 USD
Event Tools
  • Add to Favorites
  • Claim this event
Add to my Calendar
  • Scientific Programm
  • Online registration
  • Exhibition floorplans
  • Sponsorship &
    Exhibition consensus
  • Virtual Booths
Weather Info (monthly averages) Max Temperature: C / F Min Temperature: C / F The above data in our Weather Info table are temperature predictions for the date of the medical event for CALIFORNIA, Usa.
General Info
Event Venue:

University of California San Diego School of Medicine *

CALIFORNIA, USA Visit the Venue to read more


The University of California, San Diego School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

AMA: The University of California, San Diego School of Medicine designates this live activity for a maximum of 4.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

AAPA: AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME or a recognized state medical society. Physician assistants may receive a maximum of 4.25 hours of Category 1 credit for completing this program.

BRN: For the purpose of recertification, the American Nurses Credentialing Center accepts AMA PRA Category 1 Credits™ issued by organizations accredited by the ACCME. For the purpose of relicensure, the California Board of Registered Nursing accepts AMA PRA Category 1 Credits™ (report up to 4.25 hours of credit and list “CME Category 1” as the provider number).

Concerned Audience:
  • Medical_Professionals
  • Medical_students
  • Nurses
Event Overview
Welcome message:

Dear Colleague,

Rheumatologists have witnessed many exciting and important developments in the diagnostic and therapeutic approaches to patients with rheumatologic disorders. For well over a decade, greater understanding of the immunologic basis of autoimmune disorders has resulted in the introduction of targeted biologic therapies in the clinic. Novel agents have revolutionized the care of patients with diverse rheumatologic disorders including rheumatoid arthritis (RA), psoriatic arthritis (PsA), ankylosing spondylitis (AS), systemic lupus erythematosus (SLE), gout, vasculitis, and others. Driven by the success of such therapeutic advances, there has been tremendous research and interest in developing additional therapies. Moreover, both newer as well as established therapies are being used in novel treatment paradigms that have the promise of achieving better clinical outcomes for our patients. Arguably even more notable than the progress in the therapeutic approach to rheumatic diseases has been the important developments related to diagnosis and stratification of patients. For example, committees from the American College of Rheumatology (ACR), and the European League Against Rheumatism (EULAR) have published new classification criteria for RA as well as criteria for defining remission. In other areas – notably safety – new data remains an area of interest.

Because of rapid progress in the field, the latest developments are often highlighted at scientific congresses. In many cases, information from clinical trials is presented at meetings many months or even years ahead of its ultimate publication in journals. Scientific data appears in the media or on the Internet long before it is presented in medical journals! Because this important new information is relevant to the clinical care of patients, it is critical that the latest information be rapidly disseminated. Hence, there is great value in a careful and systematic review of the latest information, for example, data presented at rheumatology congresses; in particular, the annual meetings of the ACR and the EULAR. In order to accomplish this we have assembled an outstanding faculty of superlative lecturers who have extensive expertise in these areas.

Arthur Kavanaugh, MD

Mark Genovese, MDProfessor of Immunology & Rheumatology
Stanford University
Stanford, California
Registration Needs updating Register Now


Registration Cost
Early Registration

Late Registration From: 2014-11-14 To: 0--
On site Registration
General Registration

Group Registrations:

Group registrations not allowed

Accompanying Persons:

Accompanying persons not allowed

Registration Documents:
Letter of invitation:
We don’t provide letter of invitation
Letter of confirmation:
We don’t provide Letter of Confirmation
Proof of professional / educational status:
We don’t need Proof of professional/educational status
Online Abstract Submission:

We don’t accept Online Abstracts


University of California, San Diego 
Skaggs School of Pharmacy and Pharmaceutical Sciences 
9500 Gilman Drive 
La Jolla, CA 92093-0657

Once you turn onto Osler Lane off of Gilman Drive, you will take the second right down a slight hill into lot P604. The building (#873) is located right across the street on the corner of Osler Lane. The meeting will be held in the lower level, so please take the stairs that are located right on the corner down to the building entrance as the doors upstairs 

Scientific Content Up to Date
Submission Info
Sponsors Exhibitors
General Info
Maureen Helinski Clarke, CMP
Program Manager 
Phone: (619) 543-7563
Fax: (619) 543-7610 
Organising Agency

Registration and Program Information

UC San Diego Continuing Medical Education
2251 San Diego Ave., A-160
San Diego, CA 92110-2981
Phone: (619) 543-7602 or (888) 229-6263
Fax: (619) 543-7653

Event map
Revelant Events